<DOC>
	<DOCNO>NCT01245231</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study study prognostic biomarkers cell sample young patient acute myeloid leukemia .</brief_summary>
	<brief_title>Prognostic Biomarkers Samples From Young Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine percentage primary acute myeloid leukemia ( AML ) sample increase Stat3 signal pathway activity . - To evaluate presence constitutive Stat3 activation sensitivity Stat3 activation low- high-doses cytokine . - To evaluate expression level Stat3 protein upstream downstream regulator Stat3 activation . Secondary - To classify sample accord Stat3 activation pattern correlate result event-free survival ( EFS ) overall survival ( OS ) . OUTLINE : Cryopreserved AML specimens analyze pStat3 pStat5 level , response cytokine level , expression level protein know influence stat activity flow cytometry western blot assay . Results also compare prognostic variable determine CCG-291 study , include age , race , WBC , cytogenetic risk .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia ( AML ) Cryopreserved AML specimen PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
</DOC>